Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anemia, Refractory × Idarubicin × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 36 Leukemia 15 Congenital Abnormalities 9 Leukemia, Monocytic, Acute 8 Leukemia, Myelomonocytic, Acute 7 Leukemia, Megakaryoblastic, Acute 6 Leukemia, Erythroblastic, Acute 6 Myelodysplastic Syndromes 5 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Eosinophilic, Acute 3 Anemia, Refractory, with Excess of Blasts 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Basophilic, Acute 2 Neoplasms 1 Myeloproliferative Disorders 1 Liver Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

fludarabine phosphate 9 Cyclophosphamide 9 Whole-Body Irradiation 8 Mycophenolic Acid 8 Cyclosporine 8 Cord Blood Stem Cell Transplantation 8 Busulfan 4 fludarabine 3 Thiotepa 3 Tacrolimus 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Melphalan 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Etoposide 3 Antilymphocyte Serum 3 Methotrexate 2 Decitabine 2 Cytarabine 2 Cyclosporins 2 vatalanib 1 poly ICLC 1 merphos 1 lintuzumab 1 Vorinostat 1 Nivolumab 1 Microarray Analysis 1 Methylprednisolone 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡